$327M Risperdal Fine Against J&J Unit Cut In Half
The South Carolina Supreme Court on Wednesday slashed more than half of a $327 million penalty levied on a Johnson & Johnson subsidiary for whitewashing links between its anti-psychotic drug Risperdal...To view the full article, register now.
Already a subscriber? Click here to view full article